Skip to content
Agentic OS
Menu

Intelligence / Healthtech / De Novo Grants / Cytocell Limited

Approvalsnovel device granted (FDA De Novo)19 Sept 2025

Cytocell Limited

19 Sept 2025: Novel device granted (FDA De Novo) · KMT2A Breakapart FISH Probe Kit PDx (CDA-LPH013). Recorded in the openFDA device 510(k) (De Novo decisions).

View the source record

Granted
19 Sept 2025
Device
KMT2A Breakapart FISH Probe Kit PDx (CDA-LPH013)
Specialty
Hematology
Product Code
SFS
Country
United Kingdom
Location
Cambridge, United Kingdom
Submitted
2024-11-22
Reference
DEN240067
What this signal means

A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.

  1. 2 added in the 30 days to 19 Nov 2026.
  2. Neurology leads (10); 29% went to makers outside the US.
Reach them with AOS

Find the decision makers at Cytocell Limited

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

More in Hematology

De Novo Grants

See all

Source: openFDA device 510(k) (De Novo decisions), data to 19 Nov 2026. Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code. AOS shows what the public record says; it does not verify or endorse the company.